Dissociation between the increase in systemic vascular resistance induced by acute nitric oxide synthesis inhibition...

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Nitric oxide (NO) plays a crucial role in regulating vascular tone.
• Inhibition of NO synthesis is known to increase systemic vascular resistance (SVR) and decrease cardiac output (CO).

Purpose of the Study:

• To investigate the role of systemic vascular resistance (SVR) in the decrease of cardiac output (CO) following nitric oxide (NO) synthesis inhibition.
• To determine if vasodilators sodium nitroprusside (SNP) and iloprost can prevent the reduction in CO induced by L-NAME.

Main Methods:

• Anesthetized dogs were administered N omega-nitro-L-arginine methyl ester (L-NAME) to inhibit NO synthesis.
• Cardiac output (CO), systemic vascular resistance (SVR), mean arterial blood pressure (MABP), and heart rate were measured.
• The effects of SNP and iloprost on these parameters were evaluated.

Main Results:

• L-NAME induced a dose-dependent increase in MABP and SVR, accompanied by a decrease in CO and heart rate.
• SNP and iloprost abolished L-NAME-induced hypertension and attenuated the increase in SVR.
• Neither SNP nor iloprost prevented the decrease in CO induced by L-NAME.

Conclusions:

• The increase in systemic vascular resistance (SVR) is not the primary factor responsible for the decrease in cardiac output (CO) after short-term NO synthesis inhibition.
• Vasodilators can mitigate hypertension and SVR increases but do not restore cardiac output in this model.